CELLEBRITE DI LTD (CLBT) Stock Fundamental Analysis
NASDAQ:CLBT - Nasdaq - IL0011794802 - Common Stock - Currency: USD
Overall CLBT gets a fundamental rating of 5 out of 10. We evaluated CLBT against 282 industry peers in the Software industry. CLBT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CLBT is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
CLBT had positive earnings in the past year.
CLBT had a positive operating cash flow in the past year.
In multiple years CLBT reported negative net income over the last 5 years.
In the past 5 years CLBT always reported a positive cash flow from operatings.
1.2 Ratios
CLBT has a worse Return On Assets (-27.36%) than 70.32% of its industry peers.
CLBT has a worse Return On Equity (-53.44%) than 68.55% of its industry peers.
The Return On Invested Capital of CLBT (11.22%) is better than 87.63% of its industry peers.
CLBT had an Average Return On Invested Capital over the past 3 years of 7.06%. This is significantly below the industry average of 12.65%.
The 3 year average ROIC (7.06%) for CLBT is below the current ROIC(11.22%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -27.36% | ||
| ROE | -53.44% | ||
| ROIC | 11.22% |
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
1.3 Margins
With an excellent Operating Margin value of 14.30%, CLBT belongs to the best of the industry, outperforming 81.63% of the companies in the same industry.
CLBT's Operating Margin has improved in the last couple of years.
CLBT's Gross Margin of 84.06% is amongst the best of the industry. CLBT outperforms 92.23% of its industry peers.
In the last couple of years the Gross Margin of CLBT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.3% | ||
| PM (TTM) | N/A | ||
| GM | 84.06% |
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CLBT is creating some value.
CLBT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CLBT has been increased compared to 5 years ago.
CLBT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 8.12 indicates that CLBT is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.12, CLBT belongs to the top of the industry, outperforming 80.57% of the companies in the same industry.
CLBT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 8.12 |
ROIC/WACC1.24
WACC9.08%
2.3 Liquidity
A Current Ratio of 1.82 indicates that CLBT should not have too much problems paying its short term obligations.
CLBT's Current ratio of 1.82 is in line compared to the rest of the industry. CLBT outperforms 57.95% of its industry peers.
A Quick Ratio of 1.79 indicates that CLBT should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.79, CLBT is in line with its industry, outperforming 57.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.79 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 27.91% over the past year.
The Revenue has grown by 22.05% in the past year. This is a very strong growth!
The Revenue has been growing by 18.47% on average over the past years. This is quite good.
EPS 1Y (TTM)27.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)22.05%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%20.06%
3.2 Future
CLBT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.94% yearly.
CLBT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.03% yearly.
EPS Next Y11.44%
EPS Next 2Y10.76%
EPS Next 3Y14.31%
EPS Next 5Y12.94%
Revenue Next Year18.93%
Revenue Next 2Y18.12%
Revenue Next 3Y17.9%
Revenue Next 5Y16.03%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
CLBT is valuated quite expensively with a Price/Earnings ratio of 39.11.
CLBT's Price/Earnings ratio is a bit cheaper when compared to the industry. CLBT is cheaper than 63.25% of the companies in the same industry.
CLBT is valuated expensively when we compare the Price/Earnings ratio to 25.91, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 33.40, which means the current valuation is very expensive for CLBT.
CLBT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CLBT is cheaper than 60.42% of the companies in the same industry.
CLBT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.77.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.11 | ||
| Fwd PE | 33.4 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLBT indicates a somewhat cheap valuation: CLBT is cheaper than 66.78% of the companies listed in the same industry.
72.08% of the companies in the same industry are more expensive than CLBT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 31.18 | ||
| EV/EBITDA | 48.13 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CLBT's earnings are expected to grow with 14.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.42
PEG (5Y)N/A
EPS Next 2Y10.76%
EPS Next 3Y14.31%
5. Dividend
5.1 Amount
CLBT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
17.21
+0.5 (+2.99%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners44.71%
Inst Owner Change2.13%
Ins Owners2.97%
Ins Owner ChangeN/A
Market Cap4.12B
Analysts84.29
Price Target27.88 (62%)
Short Float %0.85%
Short Ratio0.89
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.43%
Min EPS beat(2)0.93%
Max EPS beat(2)15.93%
EPS beat(4)4
Avg EPS beat(4)40.28%
Min EPS beat(4)0.93%
Max EPS beat(4)86.74%
EPS beat(8)8
Avg EPS beat(8)63.98%
EPS beat(12)10
Avg EPS beat(12)43.82%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.92%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)-0.26%
Revenue beat(4)2
Avg Revenue beat(4)0.31%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)2.78%
Revenue beat(8)6
Avg Revenue beat(8)1.51%
Revenue beat(12)7
Avg Revenue beat(12)-0.3%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.8%
PT rev (3m)-1.8%
EPS NQ rev (1m)9.94%
EPS NQ rev (3m)18.07%
EPS NY rev (1m)10.23%
EPS NY rev (3m)8.73%
Revenue NQ rev (1m)-2.6%
Revenue NQ rev (3m)-0.65%
Revenue NY rev (1m)-1.9%
Revenue NY rev (3m)-1.9%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.11 | ||
| Fwd PE | 33.4 | ||
| P/S | 9.83 | ||
| P/FCF | 31.18 | ||
| P/OCF | 28.82 | ||
| P/B | 11.34 | ||
| P/tB | 12.73 | ||
| EV/EBITDA | 48.13 |
EPS(TTM)0.44
EY2.56%
EPS(NY)0.52
Fwd EY2.99%
FCF(TTM)0.55
FCFY3.21%
OCF(TTM)0.6
OCFY3.47%
SpS1.75
BVpS1.52
TBVpS1.35
PEG (NY)3.42
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -27.36% | ||
| ROE | -53.44% | ||
| ROCE | 14.2% | ||
| ROIC | 11.22% | ||
| ROICexc | 375.49% | ||
| ROICexgc | N/A | ||
| OM | 14.3% | ||
| PM (TTM) | N/A | ||
| GM | 84.06% | ||
| FCFM | 31.53% |
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.94%
ROCE(5y)9.6%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
F-Score4
Asset Turnover0.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 102.56% | ||
| Cap/Sales | 2.58% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 202.89% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.79 | ||
| Altman-Z | 8.12 |
F-Score4
WACC9.08%
ROIC/WACC1.24
Cap/Depr(3y)92.67%
Cap/Depr(5y)99.76%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y11.44%
EPS Next 2Y10.76%
EPS Next 3Y14.31%
EPS Next 5Y12.94%
Revenue 1Y (TTM)22.05%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%20.06%
Revenue Next Year18.93%
Revenue Next 2Y18.12%
Revenue Next 3Y17.9%
Revenue Next 5Y16.03%
EBIT growth 1Y41.52%
EBIT growth 3Y30.51%
EBIT growth 5YN/A
EBIT Next Year30.19%
EBIT Next 3Y22.99%
EBIT Next 5Y19.18%
FCF growth 1Y269.63%
FCF growth 3Y63.25%
FCF growth 5Y65.07%
OCF growth 1Y228%
OCF growth 3Y54.2%
OCF growth 5Y52.3%